MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE VANTAGE WITH SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED3-027-600-40 |
Device Problems
Positioning Failure (1158); Unintended Movement (3026); Activation Failure (3270); Physical Resistance/Sticking (4012)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/23/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that the patient was undergoing complex treatment of a fusiform internal carotid artery (ica) aneurysm.The catheter was looped inside the aneurysm to get it to the distal landing zone.The placement of the flow diverter failed due to inadequate opening and then as a result of manipulating losing the distal landing zone.The physician decided to take phenom27 and ped3 out and start again with a new setting.He was able to open a new ped3 without issues and finished with a good result.The patient is in good condition. the pipeline failed to open in the proximal and middle portions.The middle of the pipeline was positioned in a bend.Less than 50% of the pipeline had been deployed when it failed to open.The pipeline was resheathed less than or equal to 2 times.There were no additional steps or other devices required to open the pipeline.The pipeline was resheathed and removed from the patient with the microcatheter.The pipeline was used for an approved indication.The device and any accessories were prepared as indicated in the ifu.The catheter was flushed as indicated in the ifu.No patient symptoms or further complications were reported as a result of this event.The patient was undergoing surgery for treatment of a fusiform, unruptured right ica cavernous extradural aneurysm.The landing zone was 5.0mm distally and 5.8mm proximally.The access vessel was the ica with a diameter of 5-6mm.It was noted the patient's vessel tortuosity was severe.Dual antiplatelet therapy (dapt) was administered.The angiographic result post procedure was tici 3.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received that there were not multiple pipeline devices being used when movement occurred.It was noted that there was friction during delivery or positioning but probably because of the loops inside the giant aneurysm that the microcatheter and ped3 had to follow.The device jumped during deployment.When pushing the flow diverter, the microcatheter moved back automatically.The cause of migration was noted to be probably too much force within the system cause but the many loops.With the second ped3, the physician was able to straighten the setup, so the microcatheter and flow diverter didn't have to follow the loops inside the aneurysm.The pipeline was not implanted at the intended location and was removed.
|
|
Search Alerts/Recalls
|
|
|